Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: Optimal Timing of Hepatitis B Vaccination After Transplants [Phase 3]

View source ↗

Summary

A Phase 3 trial update discusses the optimal timing of Hepatitis B vaccination after transplantation and notes that recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Transplant-Related Disorder, Hepatitis B Virus Infection | Phase 3 | Status: NOT_YET_RECRUITING